| Overview |
| bsm-90067r-50µL |
| IKK α Recombinant Antbody Kit (KD-Validated) |
| WB, FCM |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human IKK α |
| 1-59/745 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 1147 |
| O15111 |
| CHUK; Component Of Inhibitor Of Nuclear Factor Kappa B Kinase Complex; IKK-Alpha; NFKBIKA; IKK1; IKKA; Inhibitor Of Nuclear Factor Kappa-B Kinase Subunit Alpha; Conserved Helix-Loop-Helix Ubiquitous Kinase; IkBKA; TCF16; Transcription Factor 16; I-Kappa-B Kinase 1; EC 2.7.11.10; IKK-1; Nuclear Factor NF-Kappa-B Inhibitor Kinase Alpha; Nuclear Factor NFkappaB Inhibitor Kinase Alpha; IkB Kinase Alpha Subunit; I-Kappa-B Kinase-Alpha; I-Kappa-B Kinase Alpha; I-Kappa-B Kinase; IkappaB Kinase; IKK-A Kinase; EC 2.7.11; TCF-16; IKBKA; IKK-A; BPS2 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |